Wave Life Sciences Ltd (NASDAQ: WVE) on Monday, soared 4.34% from the previous trading day, before settling in for the closing price of $14.27. Within the past 52 weeks, WVE’s price has moved between $3.50 and $16.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 610.91% over the past five years. The company achieved an average annual earnings per share of -112.96%. With a float of $118.14 million, this company’s outstanding shares have now reached $119.16 million.
Let’s look at the performance matrix of the company that is accounted for 268 employees. In terms of profitability, gross margin is 16.52%, operating margin of -283.63%, and the pretax margin is -265.84%.
Wave Life Sciences Ltd (WVE) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Wave Life Sciences Ltd is 22.54%, while institutional ownership is 73.91%. The most recent insider transaction that took place on Nov 25 ’24, was worth 750,000. Before that another transaction happened on Nov 15 ’24, when Company’s President and CEO sold 51,234 for $14.32, making the entire transaction worth $733,671. This insider now owns 217,351 shares in total.
Wave Life Sciences Ltd (WVE) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -112.96% per share during the next fiscal year.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Wave Life Sciences Ltd (WVE) is currently performing well based on its current performance indicators. A quick ratio of 1.90 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 42.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.11, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -1.06 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 1.11 million, a negative change from its year-to-date volume of 1.12 million. As of the previous 9 days, the stock’s Stochastic %D was 45.43%. Additionally, its Average True Range was 1.01.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 84.22%, which indicates a significant increase from 54.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 85.41% in the past 14 days, which was lower than the 128.70% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.75, while its 200-day Moving Average is $7.18. Nevertheless, the first resistance level for the watch stands at $15.20 in the near term. At $15.50, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.92. If the price goes on to break the first support level at $14.48, it is likely to go to the next support level at $14.06. The third support level lies at $13.76 if the price breaches the second support level.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
Market capitalization of the company is 2.26 billion based on 152,520K outstanding shares. Right now, sales total 113,310 K and income totals -57,510 K. The company made 19,690 K in profit during its latest quarter, and -32,920 K in sales during its previous quarter.
